Resistance to Type 2 Diabetes Mellitus: a Matter of Hormesis?

Overview

Journal Nat Rev Endocrinol

Specialty Endocrinology

Date 2011 Oct 26

PMID 22024974

Citations 44

Authors

Hubert Kolb

Decio L Eizirik

Affiliations

Soon will be listed here.

Abstract

Type 2 diabetes mellitus is characterized by subclinical systemic inflammation and impaired regulation of blood glucose levels. Interestingly, impairment of glycemic control occurs despite substantial insulin secretion early in the course of this disease. Dysfunction of several organs (including pancreatic islets, liver, skeletal muscle, adipose tissue, gut, hypothalamus and the immune system) has been implicated in the pathogenesis of type 2 diabetes mellitus. However, diabetes-promoting lifestyle factors do not inevitably cause disease in all persons exposed. Hence, defense mechanisms must exist that can keep the detrimental influence of these risk factors at bay. Hormesis describes the phenomenon that exposure to a mild stressor confers resistance to subsequent, otherwise harmful, conditions of increased stress. This Review discusses the emerging concept that the effectiveness of an adaptive (hormetic) response to detrimental lifestyle factors determines the extent of protection from progression to type 2 diabetes mellitus. Further analysis of these protective hormetic responses at the molecular level should help to identify novel targets for preventive or therapeutic intervention in patients at risk of developing type 2 diabetes mellitus or those with overt disease.

Citing Articles

Ambient pollution at hip fracture units and impact on mortality and post-operative delirium: A hormetic effect?.

Uzoigwe C, Bin Qadir R, Daoub A PLoS One. 2024; 19(12):e0315824.

PMID: 39705257 PMC: 11661633. DOI: 10.1371/journal.pone.0315824.

Onset of Type 2 diabetes in adults aged 50 and older in Europe: an intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy.

OSullivan J, Alonso-Perez E, Farber F, Fuellen G, Rudolf H, Heisig J Diabetol Metab Syndr. 2024; 16(1):291.

PMID: 39609833 PMC: 11605936. DOI: 10.1186/s13098-024-01533-3.

Novel sulfonamide derivatives as multitarget antidiabetic agents: design, synthesis, and biological evaluation.

Ayoup M, Khaled N, Abdel-Hamid H, Ghareeb D, Nasr S, Omer A RSC Adv. 2024; 14(11):7664-7675.

PMID: 38440282 PMC: 10910856. DOI: 10.1039/d4ra01060d.

Stress-induced β cell early senescence confers protection against type 1 diabetes.

Lee H, Sahin G, Chen C, Sonthalia S, Canas S, Oktay H Cell Metab. 2023; 35(12):2200-2215.e9.

PMID: 37949065 PMC: 10842515. DOI: 10.1016/j.cmet.2023.10.014.

Insulin and aging - a disappointing relationship.

Kolb H, Kempf K, Martin S Front Endocrinol (Lausanne). 2023; 14:1261298.

PMID: 37854186 PMC: 10579801. DOI: 10.3389/fendo.2023.1261298.

References

Olsen D, Scheede-Bergdahl C, Reving D, Boushel R, Dela F . The effect of rowing on endothelial function and insulin action in healthy controls and in patients with type 2 diabetes. Scand J Med Sci Sports. 2010; 21(3):420-30. DOI: 10.1111/j.1600-0838.2009.01012.x. View

Kars M, Yang L, Gregor M, Mohammed B, Pietka T, Finck B . Tauroursodeoxycholic Acid may improve liver and muscle but not adipose tissue insulin sensitivity in obese men and women. Diabetes. 2010; 59(8):1899-905. PMC: 2911053. DOI: 10.2337/db10-0308. View

Dasu M, Devaraj S, Zhao L, Hwang D, Jialal I . High glucose induces toll-like receptor expression in human monocytes: mechanism of activation. Diabetes. 2008; 57(11):3090-8. PMC: 2570406. DOI: 10.2337/db08-0564. View

Ozcan U, Cao Q, Yilmaz E, Lee A, Iwakoshi N, Ozdelen E . Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science. 2004; 306(5695):457-61. DOI: 10.1126/science.1103160. View

Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M . Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002; 106(16):2067-72. DOI: 10.1161/01.cir.0000034509.14906.ae. View

Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P . Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr. 2010; 64(10):1043-51. DOI: 10.1038/ejcn.2010.114. View

Lee S, Hwang A, Kenyon C . Inhibition of respiration extends C. elegans life span via reactive oxygen species that increase HIF-1 activity. Curr Biol. 2010; 20(23):2131-6. PMC: 3058811. DOI: 10.1016/j.cub.2010.10.057. View

Jordan S, Konner A, Bruning J . Sensing the fuels: glucose and lipid signaling in the CNS controlling energy homeostasis. Cell Mol Life Sci. 2010; 67(19):3255-73. PMC: 2933848. DOI: 10.1007/s00018-010-0414-7. View

Blackburn P, Despres J, Lamarche B, Tremblay A, Bergeron J, Lemieux I . Postprandial variations of plasma inflammatory markers in abdominally obese men. Obesity (Silver Spring). 2006; 14(10):1747-54. DOI: 10.1038/oby.2006.201. View

10.

Kelley D, He J, Menshikova E, Ritov V . Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes. 2002; 51(10):2944-50. DOI: 10.2337/diabetes.51.10.2944. View

11.

Hotamisligil G . Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010; 140(6):900-17. PMC: 2887297. DOI: 10.1016/j.cell.2010.02.034. View

12.

Schlotterer A, Kukudov G, Bozorgmehr F, Hutter H, Du X, Oikonomou D . C. elegans as model for the study of high glucose- mediated life span reduction. Diabetes. 2009; 58(11):2450-6. PMC: 2768179. DOI: 10.2337/db09-0567. View

13.

Wu H, Kuo S, Wu S, Chuang D . High interleukin-12 production from stimulated peripheral blood mononuclear cells of type 2 diabetes patients. Cytokine. 2010; 51(3):298-304. DOI: 10.1016/j.cyto.2010.06.014. View

14.

Cheng X, Siow R, Mann G . Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway. Antioxid Redox Signal. 2010; 14(3):469-87. DOI: 10.1089/ars.2010.3283. View

15.

Bellmann K, Jaattela M, Wissing D, Burkart V, Kolb H . Heat shock protein hsp70 overexpression confers resistance against nitric oxide. FEBS Lett. 1996; 391(1-2):185-8. DOI: 10.1016/0014-5793(96)00730-2. View

16.

Mohanty P, Hamouda W, Garg R, Aljada A, Ghanim H, Dandona P . Glucose challenge stimulates reactive oxygen species (ROS) generation by leucocytes. J Clin Endocrinol Metab. 2000; 85(8):2970-3. DOI: 10.1210/jcem.85.8.6854. View

17.

Burns N, Finucane F, Hatunic M, Gilman M, Murphy M, Gasparro D . Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training. Diabetologia. 2007; 50(7):1500-8. DOI: 10.1007/s00125-007-0655-7. View

18.

Reyna S, Ghosh S, Tantiwong P, Meka C, Eagan P, Jenkinson C . Elevated toll-like receptor 4 expression and signaling in muscle from insulin-resistant subjects. Diabetes. 2008; 57(10):2595-602. PMC: 2551667. DOI: 10.2337/db08-0038. View

19.

Johnson J, Ao Z, Ao P, Li H, Dai L, He Z . Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant. 2009; 18(8):833-45. DOI: 10.3727/096368909X471198. View

20.

Calori G, Lattuada G, Piemonti L, Garancini M, Ragogna F, Villa M . Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care. 2010; 34(1):210-5. PMC: 3005463. DOI: 10.2337/dc10-0665. View